Recombinant Human Lysyl oxidase homolog 1(LOXL1),partial CSB-EP013040HU
Specifications
| 20ug / 100ug / 1mg price = 100ug |
Alternative Name(s):
Lysyl oxidase-like protein 1 ;LOL
Species: (Organism)
Homo sapiens (Human)
Gene Names:
LOXL1
Tag info:
N-terminal 6xHis-tagged
Target Protein AA Sequence:
VGSDTVRGQARHPFGFGQVPDNWREVAVGDSTGMARARTSVSQQRHGGSASSVSASAFASTYRQQPSYPQQFPYPQAPFVSQYENYDPASRTYDQGFVYYRPAGGGVGAGAAAVASAGVIYPYQPRARYEEYGGGEELPEYPPQGFYPAPERPYVPPPPPPPDGLDRRYSHSLYSEGTPGFEQAYPDPGPEAAQAHGGDPRLGWYPPYANPPPEAYGPPRALEPPYLPVRSSDTPPPGGERNGAQQGRLSVGSVYRPNQNGRGLPDLVPDPNYVQASTYVQRAHLYSLRCAAEEKCLASTAYAPEATDYDVRVLLRFPQRVKNQGTADFLPNRPRHTWEWHSCHQHYHSMDEFSHYDLLDAATGKKVAEGHKASFCLEDSTCDFGNLKRYACTSHTQGLSPGCYDTYNADIDCQWIDITDVQPGNYILKVHVNPKYIVLESDFTNNVVRCNIHYTGRYVSATNCKIVQS
Expression Region:
106-574aa
Subcellular Location:
Secreted, extracellular space
Tissue Specificity:
Expressed in ocular tissues including the iris, ciliary body, lens and optic nerve. Not detected in the retina.
Protein Length:
Partial
Pathway:
Mol. Weight:
55.8 kDa
Purity:
Greater than 90% as determined by SDS-PAGE.
Form:
Liquid or Lyophilized powder
Buffer:
If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0.
Research Areas:
Metabolism
Function:
Active on elastin and collagen substrates.
Involvement in disease:
Exfoliation syndrome (XFS)
Relevance:
Active on elastin and collagen substrates.
Reconstitution:
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Protein Families:
Lysyl oxidase family
Reference:
Association of LOXL1 gene with Finnish exfoliation syndrome patients.Lemmela S., Forsman E., Onkamo P., Nurmi H., Laivuori H., Kivela T., Puska P., Heger M., Eriksson A., Forsius H., Jarvela I.J. Hum. Genet. 54:289-297(2009)
